Overview
FrançaisABSTRACT
Well-suited to biopharmaceutical development and production of, for example, monoclonal antibodies, viral cultures, or mammal, insect and recombinant organism cell cultures, single-use bioreactors are common in research laboratories and production plants. This article describes single-use bioreactors with continuous innovations associated with their development. Suppliers offer a wide range of equipment from research lab to production scale. Permanent need for innovation in biopharmaceuticals to reduce development time, market delivery and regular increase in process productivity offers opportunities for future production units with a good market growth.
Read this article from a comprehensive knowledge base, updated and supplemented with articles reviewed by scientific committees.
Read the articleAUTHOR
-
Maurice NONUS: Doctor, research engineer - Compiègne University of Technology, Department of Industrial Process Engineering - Royallieu Research Center, Compiègne, France.
INTRODUCTION
Since the 1980s, single-use bioreactors have contributed to the research and development of biopharmaceutical and biotechnological processes in search of innovation and productivity gains. While traditional stainless steel equipment remains the norm for large-scale production, disposable or disposable single-use equipment has taken on a predominant role in laboratories and pilot workshops, for the production of clinical trial batches and even production batches. Without the need for heavy infrastructure, disposable equipment offers flexibility and time-saving in implementation, flexibility, safety, reduced cross-contamination, and eliminates the need for cleaning, disinfection and sterilization, thus requiring less capital to initialize programs and assess their feasibility and potential. Particularly well suited to animal cell cultures (free or on supports), vaccine cultures and recombinant organisms, they meet a market need for rapid testing of innovations and research feasibility. The increased volumetric capacities offered by suppliers naturally make them the tools of choice for pilot process development, production of clinical trial batches and even production. For laboratory bioreactors, rigid resin materials are replacing glass and stainless steel in reusable bioreactors, while multilayer flexible films remain the standard for the manufacture of larger-capacity 2D pouches and 3D bags. The need to shorten development times and bring bioactive molecules to market, and the steady gains in process productivity that are reducing production volumes, mean that the prospects for their use in mixed and modular workshops are bright for years to come. Animal, insect, viral and recombinant cell cultures are the future of therapies. It is therefore crucial to reduce time-to-market and costs. The wide range of equipment on offer is growing in line with suppliers' innovations, and enables culture volumes ranging from milliliters to 2,000 L to be achieved. Current limitations on the pressure resistance and mechanical strength of materials have not limited the development of this market, which is making steady progress in production units to complement or even replace the stainless steel equipment used in conventional culture propagation installations. The growing use of single-use bioreactors is creating a dynamic of permanent innovation, combined with the rapid development of new technologies for the production of active biomolecules. Innovation in the design and shaping of flexible and rigid biocompatible polymeric materials for capacities of up to 2,000 L ensures the classic elementary functions of agitation, mixing and control of physiological conditions for cell growth. In this article, we describe the constant evolution of single-use culture equipment, an essential tool in the development of biopharmaceutical processes....
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference
KEYWORDS
Single use bioreactors | Biopharmaceutical productions | Cells cultivation
This article is included in
Drugs and pharmaceuticals
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Single-use bioreactors
Bibliography
Standards and norms
Biocompatibility standards
ISO 10993-5: Biological Evaluation of Medical Devices – In Vitro Cytotoxicity
US Pharmacopeia <87> : Biological Reactivity test, In Vitro
US Pharmacopeia <88> : Biological Reactivity Test, In Vivo
European Medicines Agency A410_01 (rev2) or European Pharmacopoeia 5.2.8 : Minimizing the Risk of...
Directory
Suppliers
Applikon
Cellexus
Celltainer
Eppendorf
Infors
Kuhner
Merck Millipore
New Brunswick
Pierre Guerin
Pall
Sartorius Stedim Biotech
Thermo...
Statistical and economic data
Market
The single-use bioreactor market was valued at €190.4 million in 2014, with expected growth of 18.4% a year to €424 million by 2019.
Bioprocessing news: Single-use bioreactor market to grow ALLpaQ Packaging Group January 29, 2015
Single-Use bioreactors for Pharma World market 2013-2023 Vision gain 03.06.2013
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference